News | January 20, 2022
Green chemistry approaches to synthesis could make a big difference to pharma product outputs
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
It is the first monoclonal antibody drug for use in any animal species
ICICI Direct gives a preview on the earnings narrative for Q3FY22
This test analyses samples in VTM directly without the need for RNA extraction step
The stability is led by healthy demand in the domestic and emerging markets
Subscribe To Our Newsletter & Stay Updated
